Successes and Opportunities during the Pandemic: Reflections and Revelations from a Vaccine Development Perspective

Author:

Heaton Penny M.1,Palaniappan Kavitha2ORCID,Stona Anne‐Claire2,Vogel Silke2ORCID,Lim John C. W.2ORCID

Affiliation:

1. The Janssen Pharmaceutical Companies of Johnson & Johnson Singapore Singapore

2. Duke‐NUS Medical School, Centre of Regulatory Excellence Singapore Singapore

Abstract

The Centre of Regulatory Excellence (CoRE) launched an annual lecture series in 2021 in Singapore to honor the memory of the late Professor Sir Alasdair Breckenridge, CoRE's founding Chair, and foster dialogue on global biomedical and regulatory perspectives, challenges, and advances. The 2022 Sir Alasdair Breckenridge Lecture “Success and Opportunities in the Pandemic” was delivered by Dr Penny M Heaton, former CEO of the Bill & Melinda Gates Foundation Research Institute and current Global Therapeutics Lead for Vaccines at Johnson & Johnson. Dr Heaton highlighted key lessons on the importance of trust, collaboration, and transparency in the context of health care and vaccine production.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference10 articles.

1. WHO Coronavirus (COVID‐19) Dashboard (2022).

2. Solis‐Moreira J.COVID‐19 vaccine: How was it developed so fast? (2021).

3. Our world in data Total COVID‐19 vaccine doses administered.Our World in Data

4. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021

5. Lazar N. C.Social trust in times of crisis | The Straits Times (2020).

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Regulation in the age of calamity: Changing the regulatory paradigm;Clinical and Translational Science;2024-07

2. A Quantitative Clinical Pharmacology-Based Framework For Model-Informed Vaccine Development;Journal of Pharmaceutical Sciences;2024-01

3. Novel Therapeutic Modalities: The Future is Now;Clinical Pharmacology & Therapeutics;2023-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3